Form 4 for ANIK Anika Therapeutics, Inc.
Accepted 2022-03-07 00:00:00 ET · period of report 2022-03-04 · accession 0001171843-22-001664 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-07 | 2022-03-04 | ANIK | Colleran David | EVP, GC, Corp Sec | M - OptEx | $0.00 | +2,500 | 5,000 | +100% | $0 |
| D | 2022-03-07 | 2022-03-04 | ANIK | Colleran David | EVP, GC, Corp Sec | F - Tax | $31.06 | -734 | 4,266 | -15% | -$22.8K |
| D | 2022-03-07 | 2022-03-04 | ANIK | Colleran David | EVP, GC, Corp Sec | M - OptEx | $0.00 | -2,500 | 2,500 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-04 | M | A | 2,500 | $0.00 | 5,000 | D | — | — | (F1) Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on March 4, 2020. |
| 2 | Common | Common Stock | 2022-03-04 | F | D | 734 | $31.06 | 4,266 | D | — | — | (F2) Reflects an aggregate of 734 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 4, 2022. (F3) Reflects the closing price of ANIK common stock on March 4, 2022, the trading day on which the vesting of RSUs gave rise to tax withholding obligations. |
| 3 | Derivative | Restricted Stock Unit | 2022-03-04 | M | D | 2,500 | $0.00 | 2,500 | D | $0.00 · — to — | 2,500 Common Stock | (F4) Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 4, 2021. |